Sana Biotechnology, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -48.9% | -48.9% | -31.5% |
| FY2022 | -54.0% | -54.0% | -32.8% |
| FY2023 | -98.5% | -98.5% | -50.1% |
| FY2024 | -106.5% | -106.5% | -53.2% |
| FY2025 | -151.8% | -151.8% | -58.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -48.9% | -48.9% | -31.5% |
| FY2022 | -54.0% | -54.0% | -32.8% |
| FY2023 | -98.5% | -98.5% | -50.1% |
| FY2024 | -106.5% | -106.5% | -53.2% |
| FY2025 | -151.8% | -151.8% | -58.6% |